Qare™ Is Here: Lōkahi Therapeutics™ Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications

Glucotrack's subsidiary Lōkahi Therapeutics launched Qare, a free mobile app that matches users into cohorts by medication and demographics to compare self-reported treatment experiences, starting with GLP-1 medications. The company frames the platform as a generator of de-identified real-world data that could eventually support research and industry partnerships, but disclosed no users, revenue, or partnership commitments.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.